Provided by Tiger Trade Technology Pte. Ltd.

Virios Therapeutics, LLC

3.88
0.0000
Volume:- -
Turnover:8.00M
Market Cap:107.56M
PE:-16.67
High:3.88
Open:3.88
Low:3.88
Close:3.88
52wk High:3.88
52wk Low:0.1260
Shares:27.76M
Float Shares:25.89M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2324
EPS(LYR):-0.2821
ROE:-119.56%
ROA:-67.76%
PB:34.30
PE(LYR):-13.74

Loading ...

Company Profile

Company Name:
Virios Therapeutics, LLC
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Innovative Med Concepts, LLC and changed its name to Virios Therapeutics, Inc. in July 2020. Virios Therapeutics, Inc. was founded in 2012 and is headquartered in Alpharetta, Georgia.